5 Simple Exercises By Christina P. That Support Health in Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, posted on LinkedIn:
”Living with Antiphospholipid Syndrome (APS) or any other clotting disorder can bring fatigue, joint pain, swelling, and a higher risk of blood clots. While intense workouts may feel out of reach, gentle, simple exercises can play a powerful role in maintaining your health and well-being.
1. Improves Circulation
Regular movement helps prevent blood from pooling, especially in the legs – reducing the risk of deep vein thrombosis (DVT) and other clot-related complications.
2. Supports Joint and Muscle Health
Low-impact activity helps keep your joints flexible and muscles strong, which is important when dealing with inflammation, stiffness, or autoimmune flares.
3. Boosts Energy and Mood
Even 10 minutes of light movement a day can increase endorphins, fight fatigue, and improve mental clarity – all common challenges for people with APS.
4. Reduces Stress
Exercise helps regulate stress hormones and calm the nervous system, which may ease autoimmune flares and improve sleep.
5. You’re in Control
Simple exercises (like stretching, walking, chair yoga, or gentle resistance) can be done at your own pace, tailored to how you feel day to day.”
Stay updated with Hemostasis Today.
-
Oct 8, 2025, 03:07Stroke Education By Rodrigo Guerrero - On Unilateral, Nonprogressive Stenosis
-
Oct 7, 2025, 15:015 Simple Exercises By Christina P. That Support Health in Antiphospholipid Syndrome
-
Oct 7, 2025, 14:39Dr Amid Karad: Help Raise Awareness on Evidence-Based INR Management for Diverse Indications
-
Oct 7, 2025, 14:27NBCA Insights with Erin VanDyke: Revealing Gaps in Blood Clot Diagnosis and Support
-
Oct 7, 2025, 14:26Caitlin Raymond: When to Use Albumin vs. Plasma, and Why the Timing Matters
-
Oct 8, 2025, 04:50Christopher Cannon Shares A Study Showing No Benefit When Adding an Antiplatelet to Anticoagulant in Stroke with AF and Atherosclerosis
-
Oct 8, 2025, 04:41Claudio Laudani: We Summarize Current Knowledge and Future Perspectives On The Role of Inflammation in Patients with MI
-
Oct 8, 2025, 04:03José Antonio García Erce: Honored For Publishing in SANGRE Magazine
-
Oct 8, 2025, 03:57Mattia Galli On Genomadix Cube Test: A Rapid Genetic Test to Predict The Response to Clopidogrel
-
Oct 8, 2025, 03:54Rory R Koenen on Platelet-Derived Extracellular Vesicle Analogues from Lyophilized Platelets
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 8, 2025, 04:45Reza Shojaei: On The 2nd Day of IPAW 2025, Let's Focus on Patients, The Real Reason Plasma Matters!
-
Oct 7, 2025, 08:29“48 Poems on 48 Blood Group Systems” - Dr Bhavyaa Beriwal Blends Science and Poetry in Her New Transfusion Medicine Book
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
-
Oct 7, 2025, 04:09Svenja Tatjana Barckhausen: Reducing Reliance on U.S. Plasma – Not Just for Europe, But for The World!
-
Oct 7, 2025, 03:58Louise Bannon: Don’t Wait Until You’re Diagnosed to Learn About Blood Clots